A new randomized multicenter clinical trial has been evaluating the new artificial pancreas system. This new system can automatically regulate and monitor the glucose levels in the blood. According to the clinical trials, this new system is more efficient and effective treatment method that the existing ones. The new artificial pancreatic system can control the blood sugar and glucose levels more efficiently for people suffering from type 1 diabetes.
The clinical trial is being partly conducted at the University of Virginia Center for Diabetes Technology. This research trial received the primary funding from the National Institute of Diabetes and Digestive and Kidney Diseases. This institute is the part of the National Institutes of Health.
How Does New Artificial Pancreatic System Works?
The research shows that the new system helps in improving the blood glucose levels of the participants. The system can maintain a perfect balance both through the day and overnight. Maintaining a proper glucose level in blood is common yet serious problem in both adults and children suffering from type 1 diabetes. The blood glucose levels can drop seriously low during the sleep that can cause harm to the patient.
The research study that is now featuring in the New England Journal of Medicine says the new system is an ‘all in one’ diabetes management system. It can track the levels of glucose in the blood stream using the continuous glucose monitor. It can also automatically deliver the insulin hormone if when the need arises. This delivery occurs with the help of an insulin pump. The artificial pancreas system replaces the dependency on the existing methods such as fingertip testing or constant glucose monitoring. It also helps in reducing the dependency on independent delivery of insulin several times a day through an injection or a pump.